In early 2023, the Biden administration prepared for legal challenges aimed at overturning the FDA's approval of mifepristone, a drug used in over half of U.S. abortions. While the Supreme Court preserved access to the pill in 2024, current litigation in 2026 involves ongoing efforts to restrict the drug through safety studies and the Comstock Act. For detailed coverage, visit AP News .
Biden admin seeks to halt ruling suspending sale of abortion pill In early 2023, the Biden administration prepared for